Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,279,237 papers from all fields of science
Search
Sign In
Create Free Account
TD-4208
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Pharmacological properties of revefenacin (TD‐4208), a novel, nebulized long‐acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and…
S. Hegde
,
M. Pulido-Rios
,
+7 authors
J. Jasper
Pharmacology Research & Perspectives
2018
Corpus ID: 13705188
Revefenacin (TD‐4208) is a novel, long‐acting, and lung‐selective muscarinic cholinergic receptor (mAChR) antagonist in…
Expand
2018
2018
Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized…
D. Quinn
,
C. Barnes
,
+6 authors
Dave Singh
Pulmonary Pharmacology & Therapeutics
2018
Corpus ID: 33003719
Review
2017
Review
2017
Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs
M. Mastrodicasa
,
C. Droege
,
Aaron M Mulhall
,
N. Ernst
,
R. Panos
,
M. Zafar
Expert Opinion on Investigational Drugs
2017
Corpus ID: 21049467
ABSTRACT Introduction: Long acting muscarinic receptor antagonists (LAMA) reverse airflow obstruction by antagonizing para…
Expand
2014
2014
Repeated-dose pharmacokinetics of once-daily TD-4208, a long-acting muscarinic receptor antagonist (LAMA), in subjects with COPD
D. Bourdet
,
C. Barnes
,
W. Yates
,
E. Moran
,
Andrew Nicholls
,
B. Haumann
2014
Corpus ID: 73129161
Introduction TD-4208 is a lung-selective, LAMA shown to have a long duration of action and minimal systemic antimuscarinic…
Expand
2013
2013
In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models
M. Pulido-Rios
,
A. Mcnamara
,
+4 authors
Sharath S. Hegde
Journal of Pharmacology and Experimental…
2013
Corpus ID: 10106670
Tiotropium is currently the only once-daily, long-acting muscarinic antagonist (LAMA) approved in the United States and other…
Expand
2012
2012
A randomized, crossover study to examine the pharmacodynamics and safety of a new antimuscarinic (TD-4208) in COPD
P. Potgieter
,
A. Hopkins
,
Phillip Liu
,
D. Quinn
,
C. Amburgey
,
E. Moran
2012
Corpus ID: 70930185
Background: TD-4208 is a potent and selective inhaled muscarinic antagonist with functional lung selectivity and long duration in…
Expand
2009
2009
In Vitro Characterization of TD-4208, a Lung-Selective and Long-Acting Muscarinic Antagonist Bronchodilator.
T. Steinfeld
,
M. Pulido-Rios
,
+7 authors
M. Mammen
Asian Test Symposium
2009
Corpus ID: 76575007
2009
2009
TD-4208: A Novel, Lung-Selective Muscarinic Antagonist with Sustained Bronchoprotective Activity in Preclinical Models.
M. Pulido-Rios
,
A. Mcnamara
,
+4 authors
M. Mammen
Asian Test Symposium
2009
Corpus ID: 76270195
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required